Skip to main content
Femasys Inc. (FEMY)
NASDAQ: FEMY · IEX Real-Time Price · USD
1.090
-0.020 (-1.80%)
At close: Jul 19, 2024, 4:00 PM
1.070
-0.020 (-1.83%)
Pre-market: Jul 22, 2024, 7:26 AM EDT

Femasys Revenue

Femasys had revenue of $1.05M in the twelve months ending March 31, 2024. Revenue in the quarter ending March 31, 2024 was $271.14K. In the year 2023, Femasys had annual revenue of $1.07M.

Revenue (ttm)
$1.05M
Revenue Growth
-11.00%
P/S Ratio
23.09
Revenue / Employee
$30,857
Employees
34
Market Cap
24.22M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20231.07M-134.25K-11.13%
Dec 31, 20221.21M26.53K2.25%
Dec 31, 20211.18M141.77K13.66%
Dec 31, 20201.04M108.85K11.72%
Dec 31, 2019929.06K--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Trinity Biotech 56.71M
Nephros 14.06M
NeuroOne Medical Technologies 3.73M
Biora Therapeutics 544.00K
AIM ImmunoTech 193.00K
Revenue Rankings

FEMY News

More News